Dental Cervical Non-carious Lesion

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

GC Biopharma
GC BiopharmaKorea - Yongin
1 program
Equia ForteN/A1 trial
Active Trials
NCT02631161CompletedEst. Feb 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GC BiopharmaEquia Forte

Clinical Trials (1)

NCT02631161GC BiopharmaEquia Forte

Glass Hybrid Versus Composite Restorations of Non-carious Cervical Lesions

Start: Dec 2015Est. completion: Feb 2021
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space